
Petra provides AI-powered diagnostics that identify patients at risk of developing diabetic foot ulcers to help clinicians intervene earlier. The company uses machine learning–based medical imaging and predictive algorithms to analyze clinical data and wound images for risk stratification. Petra positions itself as a medical AI diagnostics provider for healthcare providers and clinics. The product is aimed at integrating into clinical workflows to support screening and triage decisions. It addresses a large clinical need in diabetic wound care with the goal of reducing ulcer-related complications and amputations.

Petra provides AI-powered diagnostics that identify patients at risk of developing diabetic foot ulcers to help clinicians intervene earlier. The company uses machine learning–based medical imaging and predictive algorithms to analyze clinical data and wound images for risk stratification. Petra positions itself as a medical AI diagnostics provider for healthcare providers and clinics. The product is aimed at integrating into clinical workflows to support screening and triage decisions. It addresses a large clinical need in diabetic wound care with the goal of reducing ulcer-related complications and amputations.
Core product: AI-powered diagnostics for identifying patients at risk of diabetic foot ulcers
Founded: 2021
Industry: Biotechnology
Team size (reported): 4 employees
Diabetic wound care — screening and risk stratification to prevent ulcers and amputations.
2021
Biotechnology